Clinical Trials › NCT05740722
RecruitingPhase 2
Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis
Sponsored by Haukeland University Hospital
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 300
Target enrollment
May 2023
Start date
Dec 2027
Expected completion
Interventions / Treatments
Nicotinamid ribosidePlacebo
Conditions studied
Multiple SclerosisProgressive Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.